NCT02264379View on ClinicalTrials.gov

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2020

Study Completion Date

August 31, 2021

Conditions
Oligometastatic DiseaseProstate Cancer
Interventions
RADIATION

normal fractionated irradiation

25\*2 Gy (once a day, 5 days a week)

RADIATION

hypo fractionated irradiation

3\*10 Gy (once a day, 2-3 days a week)

Trial Locations (2)

72016

Universitätsklinikum Tübingen, Department of Radiation Therapy and Radiation Oncology, Tübingen

01307

Technische Universität Dresden, University Hospital Carl Gustav Carus, Department of Radiation Therapy and Radiation Oncology, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT02264379 - Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma | Biotech Hunter | Biotech Hunter